As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

The FDA has released draft guidance on how sponsors can use Bayesian models for clinical trials.

Longitudinal data analysis is an essential statistical approach for studying phenomena observed repeatedly over time, allowing researchers to explore both within-subject and between-subject variations ...

However, traditional clinical trial designs are often ill-suited for rare disease research with common challenges including ...

Empirical Bayes is a versatile approach to “learn from a lot” in two ways: first, from a large number of variables and, second, from a potentially large amount of prior information, for example, ...

In this video from PyCon Australia, Rhydwyn McGuire from the The New South Wales Department of Health presents: Video: Fast, Beautiful and Easy Bayesian Modeling – Can You have it all? Bayesian models ...

Disclaimer: AlphaGalileo is not responsible for the accuracy of content posted to AlphaGalileo by contributing institutions or for the use of any information through the AlphaGalileo system.

Clinical evaluation and performance of QIAGEN Clinical Insight Interpret (QCI-I) as a reporting tool for a comprehensive cancer panel (TSO 500).

This is a preview. Log in through your library . Abstract Since longitudinal and survival data are often obtained together in applications, studies on joint modelling that reveal the relationship ...